The Market for Heart Benefit Foods

An International Global Analysis (2nd Edition)

Publication Date	March 2005
Publisher	Leatherhead
Product Type	Report
Pages	242
ISBN Number	not applicable
Product Code	LFR00020

Price

£950.00
approximately: $1,411 | €1,118

PDF

PRINT £950 ($1,411 | €1,118)

Order above formats by FAX

Summary

The report covers heart benefit foods, using a strict market definition: "everyday food and drinks products (not pills or potions) that bear a health claim implying that the product has a physiological effect over and above that of just nutrition (e.g. can help lower cholesterol as part of a low-fat diet, helps maintain a healthy heart, etc.)

The following key areas for Heart Benefit foods are covered in detail in the Market Situation section of the report:

Fats and oils - covering cholesterol-lowering and circulatory-health margarine and spread products, primarily with phytosterols/phytostanols or omega-3 fatty acids, in the US, Europe and Australia, and functional cooking oils in Japan.
Cereal products - primarily focusing on wholegrain and oat-based breakfast cereals
Soya products - mainly focusing on soya milk and soya beverages promoted on a heart-health platform
Dairy products - including yoghurts and dose-delivery drinks with phytosterols/phytostanols, and dairy products with omega-3 fatty acids and bio-active peptides.
Eggs - focusing primarily on omega-3 and DHA-fortified eggs
Bakery products - primarily breads with wholegrains
Soft drinks - including products using phytosterols, omega-3 fatty acids, and antioxidants

The Key Objectives Of This Report Are To:

Quantify the current market for Heart Benefit foods around the world, focusing on the key European markets of France, Germany, Italy, Spain and the UK; the US; Japan; and Australia
Review the relative importance and future potential of each of the major sub-sectors, looking at market, product and ingredient activity
Assess the nature and prevalence of heart and circulatory disorders, reviewing scientific evidence linking the effects of certain ingredients and elements of the diet on these conditions
Identify key product sectors for current and future development of the market, presenting an A-Z of potential heart health ingredients, discussing their technical properties, sources and availability
Highlight potential directions for future growth looking at market and product directions, as well as the indications that may be inferred from recent patent activity

Content

Introduction
- Research Scope and Definitions
- Research Method
- Information Provided
- Currency Conversions
1. Executive Summary
- 1.1 Market Size and Segmentation
- 1.2 Key Market Drivers
- 1.3 Innovation and New Product Development
- 1.4 The Regulatory Environment
- 1.5 Industry Dynamics
- 1.6 Future Prospects
2. Market Situation
- 2.1 Overview
- 2.2 Fats and Oils
  - 2.2.1 Overview
  - 2.2.2 Europe
  - 2.2.3 US
  - 2.2.4 Japan
  - 2.2.5 Australia
- 2.3 Cereal Products
  - 2.3.1 Overview
  - 2.3.2 Europe
  - 2.3.3 US
  - 2.3.4 Japan
  - 2.3.5 Australia
- 2.4 Soya Products
  - 2.4.1 Overview
  - 2.4.2 Europe
  - 2.4.3 US
  - 2.4.4 Japan
  - 2.4.5 Australia
- 2.5 Dairy Products
  - 2.5.1 Overview
  - 2.5.2 Europe
  - 2.5.3 US
  - 2.5.4 Japan
  - 2.5.5 Australia
- 2.6 Eggs
  - 2.6.1 Overview
  - 2.6.2 Europe
  - 2.6.3 US
  - 2.6.4 Japan
  - 2.6.5 Australia
- 2.7 Bakery Products
  - 2.7.1 Overview
  - 2.7.2 Europe
  - 2.7.3 US
  - 2.7.4 Japan
  - 2.7.5 Australia
- 2.8 Soft Drinks
  - 2.8.1 Overview
  - 2.8.2 Europe
  - 2.8.3 US
  - 2.8.4 Japan
  - 2.8.5 Australia
3. Product Trends
- 3.1 Overview
  - 3.1.1 Overview
  - 3.1.2 Europe
  - 3.1.3 US
  - 3.1.4 Japan
  - 3.1.5 Australia
- 3.2 Cholesterol-lowering Foods and Drinks
  - 3.2.1 Phytosterols/phytostanols
  - 3.2.2 Soya protein
  - 3.2.3 Oat bran/beta-glucan
  - 3.2.4 Psyllium
  - 3.2.5 Wholegrains
- 3.3 Circulatory Health Foods and Drinks
  - 3.3.1 Omega-3/DHA
- 3.4 Anti-hypertensive Foods and Drinks
  - 3.4.1 Bioactive peptides
  - 3.4.2 Potassium
- 3.5 Antioxidant Heart Health Foods and Drinks
4. Heart And Circulatory Disease
- 4.1 Summary
- 4.2 Prevalence by Country and Trends in Incidence
  - 4.2.1 Variation in circulatory disease death rates across countries
  - 4.2.2 Influence of gender and age on death rates from circulatory disease
  - 4.2.3 Variation in hypertensive disease death rates across countries
  - 4.2.4 Death rates from cerebrovascular disease
- 4.3 Background to Cardiovascular Disease (CVD)
  - 4.3.1 Development of cardiovascular disease
- 4.4 Summary of Risk Factors
  - 4.4.1 Types of evidence
  - 4.4.2 Categories of risk factors for coronary heart disease (CHD)
  - 4.4.3 Controllable risk factors - physiological
  - 4.4.4 Lifestyle
  - 4.4.5 Uncontrollable risk factors
  - 4.4.6 Early development
  - 4.4.7 Medical conditions that increase risk of CHD
  - 4.4.8 Prevention
- 4.5 References
- 4.6 Further Reading
5. Effect Of Diet: Current And Potential Heart Health Ingredients
- 5.1 Summary
- 5.2 Principal Heart Health Dietary Factors
  - 5.2.1 Soya
  - 5.2.2 Unsaturated fatty acids
  - 5.2.3 Phytostanol and phytosterol esters
  - 5.2.4 Dietary fibre
  - 5.2.5 Antioxidant vitamins E and C
  - 5.2.6 Folic acid
  - 5.2.7 Potassium-based salt replacers
- 5.3 Other Up-and-coming Heart Health Ingredients
  - 5.3.1 Carotenoids
  - 5.3.2 Vitamins B6 and B12
  - 5.3.3 Vitamin B3 (niacin)
  - 5.3.4 Garlic
  - 5.3.5 Antioxidant polyphenols and flavonoids
  - 5.3.6 L-arginine
  - 5.3.7 Magnesium
  - 5.3.8 Bioactive peptides
  - 5.3.9 Chitosan
  - 5.3.10 Wholegrains
- 5.4 Less Well-proven Ingredients
  - 5.4.1 Conjugated linoleic acid
  - 5.4.2 Plant lignans
  - 5.4.3 Rice bean oil (contains sterols, tocotrienols gamma-oryzanol)
  - 5.4.4 Coenzyme Q10
  - 5.4.5 Betaine
  - 5.4.6 Selenium
- 5.5 References
- 5.6 Further Reading
6. Patent Review
- 6.1 Summary
- 6.2 Cholesterol-lowering Products
  - 6.2.1 Phytosterols and phytostanols
  - 6.2.2 Cholesterol-lowering soya protein products
  - 6.2.3 Soluble fibre
- 6.3 Circulatory Health
  - 6.3.1 PUFA-containing products
- 6.4 Anti-hypertensives
  - 6.4.1 Anti-hypertensive compilations
  - 6.4.2 Anti-hypertensive bioactive peptides
- 6.5 Multiple-benefit and Miscellaneous Heart-health Products
- 6.6 Polyphenols and Flavonoids
7. Heart Health Ingredients - Properties And Availability
- 7.1 Ingredients (A-Z)
  - 7.1.1 Antioxidant vitamins
  - 7.1.2 Antioxidant polyphenols and flavonoids
  - 7.1.3 Arginine
  - 7.1.4 B vitamins
  - 7.1.5 Beta-glucan
  - 7.1.6 Betaine
  - 7.1.7 Bioactive peptides
  - 7.1.8 Carotenoids
  - 7.1.9 Chitosan
  - 7.1.10 Coenzyme Q10
  - 7.1.11 Conjugated linoleic acid
  - 7.1.12 Dietary fibre
  - 7.1.13 Fibre
  - 7.1.14 Flaxseed
  - 7.1.15 Folic acid
  - 7.1.16 Garlic
  - 7.1.17 Isoflavones
  - 7.1.18 Lactic acid bacteria
  - 7.1.19 Linseed
  - 7.1.20 Magnesium
  - 7.1.21 Monounsaturated fatty acids (MUFAs)
  - 7.1.22 Mushroom nutraceuticals
  - 7.1.23 Omega-3 polyunsaturated fatty acids
  - 7.1.24 Phytochemicals
  - 7.1.25 Phytosterol and phytostanol esters
  - 7.1.26 Psyllium
  - 7.1.27 Rice bran oil
  - 7.1.28 Salt substitutes
  - 7.1.29 Saponins
  - 7.1.30 Soya
  - 7.1.31 Tocotrienols
  - 7.1.32 Vitamins
  - 7.1.33 Ubiquinone
- 7.2 Useful Web Directories for Ingredients Suppliers 25
Appendix - Colour Plates